1. Кулаков В.И., Серов В.Н., Абубакирова А.М. Анестезия + реанимация в акушерстве и гинекологии. М.: Триада, 2000.
2. Серов В.Н. Гестоз: современная лечебная тактика. Фарматека. 2004; 1: 67–71.
3. Шехтман М.М., Бурдули Г.М. Болезни органов дыхания и кровообращения у беременных. М.: Триада-Х, 2002.
4. Кулаков В.И., Мурашко Л.Е. Новые подходы к терминологии, профилактике и лечению гестоза. Акуш. и гин.1998; 5: 3–6.
5. Диагностика и лечение артериальной гипертензии. Российские рекомендации. Прил. к журн. Кардиоваскул. тер. и профилак. 2008; 2.
6. Ушкалова Е.А. Лечение артериальной гипертензии во время беременности. Фарматека. 2003; 11: 27–32.
7. Gifford RW, August PA, Cunningham G et al. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183 (1): 1–22.
8. Guidelines Committee. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 2003; 21 (6): 1011–53.
9. Helewa ME, Burrows RF, Smith J et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive discorderes in pregnancy. CMAJ 1997; 157 (6): 715–25.
10. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437.
11. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102: 181–92.
12. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–56.
13. Ткачева О.Н., Барабашкина А.В. Актуальные вопросы патогенеза, диагностики и фармакотерапии артериальной гипертонии у беременных. М.: ПАГРИ, 2006.
14. Cifkova R. Hypertension in pregnancy. Vnitr Lek 2006; 52 (3): 263–70.
15. Eskes TK. Leon C. Chesley and hypertension in pregnant women. Eur J Obstet Gynecol Repord Biol 2000; 90 (2): 181–6.
16. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiolody. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105–87.
17. The Task Force on the Management of Cardiovascular Diseases During Pregnancy on the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761–81.
18. Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России. М.: Рашин Продакшин, 2007.
19. Buttar HS. An overview of the influence of ACE inhibitors on fetal placental circulation and perinatal development. Mol Cell Biol 1997; 176: 61–71.
20. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128–35.
21. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 1992; 80: 429–32.
22. Von Dadelsen P, Ornstein MP, Bull SB et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a metaanalysis. Lancet 2000; 355: 87–92.
23. Von Dadelszen P, Menzies J, Gilgoff S et al. Evidence-based management for preeclampsia. Front Biosci 2007; 1 (12): 2876–89.
24. Астахова А.В., Лепахин В.К. Неблагоприятные побочные реакции и контроль безопасности лекарств. Руководство по фармаконадзору. М.: Когито-Центр, 2004.
________________________________________________
1. Кулаков В.И., Серов В.Н., Абубакирова А.М. Анестезия + реанимация в акушерстве и гинекологии. М.: Триада, 2000.
2. Серов В.Н. Гестоз: современная лечебная тактика. Фарматека. 2004; 1: 67–71.
3. Шехтман М.М., Бурдули Г.М. Болезни органов дыхания и кровообращения у беременных. М.: Триада-Х, 2002.
4. Кулаков В.И., Мурашко Л.Е. Новые подходы к терминологии, профилактике и лечению гестоза. Акуш. и гин.1998; 5: 3–6.
5. Диагностика и лечение артериальной гипертензии. Российские рекомендации. Прил. к журн. Кардиоваскул. тер. и профилак. 2008; 2.
6. Ушкалова Е.А. Лечение артериальной гипертензии во время беременности. Фарматека. 2003; 11: 27–32.
7. Gifford RW, August PA, Cunningham G et al. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183 (1): 1–22.
8. Guidelines Committee. 2003 European Society of Hypertension – European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 2003; 21 (6): 1011–53.
9. Helewa ME, Burrows RF, Smith J et al. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive discorderes in pregnancy. CMAJ 1997; 157 (6): 715–25.
10. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41: 437.
11. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102: 181–92.
12. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206–56.
13. Ткачева О.Н., Барабашкина А.В. Актуальные вопросы патогенеза, диагностики и фармакотерапии артериальной гипертонии у беременных. М.: ПАГРИ, 2006.
14. Cifkova R. Hypertension in pregnancy. Vnitr Lek 2006; 52 (3): 263–70.
15. Eskes TK. Leon C. Chesley and hypertension in pregnant women. Eur J Obstet Gynecol Repord Biol 2000; 90 (2): 181–6.
16. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiolody. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105–87.
17. The Task Force on the Management of Cardiovascular Diseases During Pregnancy on the European Society of Cardiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761–81.
18. Лечебно-диагностическая тактика ведения беременных с артериальной гипертонией в России. М.: Рашин Продакшин, 2007.
19. Buttar HS. An overview of the influence of ACE inhibitors on fetal placental circulation and perinatal development. Mol Cell Biol 1997; 176: 61–71.
20. Hanssens M, Keirse MJ, Vankelecom F, Van Assche FA. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol 1991; 78: 128–35.
21. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 1992; 80: 429–32.
22. Von Dadelsen P, Ornstein MP, Bull SB et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a metaanalysis. Lancet 2000; 355: 87–92.
23. Von Dadelszen P, Menzies J, Gilgoff S et al. Evidence-based management for preeclampsia. Front Biosci 2007; 1 (12): 2876–89.
24. Астахова А.В., Лепахин В.К. Неблагоприятные побочные реакции и контроль безопасности лекарств. Руководство по фармаконадзору. М.: Когито-Центр, 2004.